Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease

Saved in:
Bibliographic Details
Published in:Biology of blood and marrow transplantation 2013-04, Vol.19 (4), p.676-677
Main Authors: Radhakrishnan, Kavita, Bhatia, Monica, Geyer, Mark B, del Toro, Gustavo, Jin, Zhezhen, Baker, Courtney, Harrison, Lauren, Morris, Erin, Baxter-Lowe, Lee Ann, Cairo, Mitchell S
Format: Article
Language:English
Subjects:
Alemtuzumab
Anemia, Sickle Cell - immunology
Anemia, Sickle Cell - pathology
Anemia, Sickle Cell - therapy
Antibodies, Monoclonal, Humanized - therapeutic use
Busulfan - therapeutic use
Child
Child, Preschool
Cord Blood Stem Cell Transplantation
Female
Graft Rejection
Graft Survival - drug effects
Hematology, Oncology and Palliative Medicine
Humans
Infant
Male
Myeloablative Agonists - therapeutic use
Transplantation Conditioning
Unrelated Donors
Vidarabine - analogs & derivatives
Vidarabine - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2013.02.002